Dimensional Fund Advisors

Dimensional Fund Advisors Portfolio holdings

AUM $466B
1-Year Est. Return 20.66%
 

Dimensional Fund Advisors (DFA), founded in 1981 by David Booth and Rex Sinquefield and headquartered in Austin, Texas, is an investment management firm renowned for its evidence-based, low-cost approach to investing, grounded in academic research from Nobel laureates like Eugene Fama and Kenneth French. Managing hundreds of billions in assets, DFA focuses on systematic, passive strategies that tilt toward factors like small-cap, value, and profitability stocks, primarily through mutual funds and institutional portfolios rather than retail brokerage services. The firm’s philosophy eschews market timing and stock picking, instead emphasizing diversification and efficient market exposure, often requiring investors to access its funds through approved financial advisors. With a global presence and a reputation for disciplined, data-driven investing, DFA has carved a unique niche in the industry, blending academic rigor with practical application.

This Quarter Est. Return
1 Year Est. Return
+20.66%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$432B
AUM Growth
+$29.6B
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
3,373
New
Increased
Reduced
Closed

Top Buys

1 +$445M
2 +$405M
3 +$387M
4
JNJ icon
Johnson & Johnson
JNJ
+$256M
5
PG icon
Procter & Gamble
PG
+$170M

Top Sells

1 +$536M
2 +$471M
3 +$421M
4
JPM icon
JPMorgan Chase
JPM
+$237M
5
DE icon
Deere & Co
DE
+$235M

Sector Composition

1 Technology 20.97%
2 Financials 18.52%
3 Industrials 12.24%
4 Consumer Discretionary 10.39%
5 Healthcare 9.42%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DOMH icon
3201
Dominari Holdings
DOMH
$77.8M
$79.5K ﹤0.01%
14,612
ASTC icon
3202
Astrotech Corp
ASTC
$5.77M
$79.5K ﹤0.01%
13,759
+1,677
SGRP icon
3203
SPAR Group
SGRP
$24.9M
$79.1K ﹤0.01%
82,400
-5,599
SOPH icon
3204
SOPHiA GENETICS
SOPH
$297M
$77.9K ﹤0.01%
25,127
SLNG icon
3205
Stabilis Solutions
SLNG
$89.8M
$77.5K ﹤0.01%
16,316
NMRA icon
3206
Neumora Therapeutics
NMRA
$449M
$77K ﹤0.01%
104,983
-83,435
EP icon
3207
Empire Petroleum
EP
$105M
$76.6K ﹤0.01%
14,460
-4,406
DMAC icon
3208
DiaMedica Therapeutics
DMAC
$280M
$75.4K ﹤0.01%
19,339
LPCN icon
3209
Lipocine
LPCN
$15.3M
$75.4K ﹤0.01%
23,862
-1,073
TDUP icon
3210
ThredUp
TDUP
$935M
$75K ﹤0.01%
10,055
-66,449
LSTA icon
3211
Lisata Therapeutics
LSTA
$18.3M
$74.3K ﹤0.01%
25,793
+571
IMMP
3212
Immutep
IMMP
$271M
$74.1K ﹤0.01%
45,167
-322
IPWR icon
3213
Ideal Power
IPWR
$31.5M
$72K ﹤0.01%
15,889
+5,578
USIO icon
3214
Usio Inc
USIO
$37.6M
$71K ﹤0.01%
46,421
PLX icon
3215
Protalix BioTherapeutics
PLX
$154M
$67.7K ﹤0.01%
+45,571
SERA icon
3216
Sera Prognostics
SERA
$112M
$66.9K ﹤0.01%
22,424
-14,005
IRWD icon
3217
Ironwood Pharmaceuticals
IRWD
$548M
$64.8K ﹤0.01%
90,373
-28
ALMS
3218
Alumis Inc
ALMS
$549M
$64.6K ﹤0.01%
+21,540
NVNO icon
3219
enVVeno Medical
NVNO
$13.2M
$64.3K ﹤0.01%
16,119
BMEA icon
3220
Biomea Fusion
BMEA
$91.2M
$63.8K ﹤0.01%
35,411
-23,897
CNF
3221
CNFinance Holdings
CNF
$35.2M
$62.6K ﹤0.01%
9,651
-5,379
ZYXI icon
3222
Zynex
ZYXI
$23.6M
$61.7K ﹤0.01%
23,924
-8
KLXE icon
3223
KLX Energy Services
KLXE
$29.3M
$61.1K ﹤0.01%
32,667
-20,188
BRN icon
3224
Barnwell Industries
BRN
$11.9M
$60.7K ﹤0.01%
53,704
OBIO icon
3225
Orchestra BioMed
OBIO
$236M
$59.7K ﹤0.01%
+22,207